1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Imaging Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Key Insights
5.1. Technological Advancements
5.2. Veterinary Imaging & Prevalence Rate of Veterinary Conditions
5.3. COVID-19 Pandemic Impact on Industry
6. Global Veterinary Imaging Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Equipment
6.3.1.1. Radiography (X-ray)
6.3.1.2. Ultrasound Imaging
6.3.1.3. Magnetic Resonance Imaging (MRI)
6.3.1.4. Computed Tomography
6.3.1.5. Endoscopy
6.3.1.6. Others
6.3.2. Imaging Reagents
6.3.3. Imaging Software
6.4. Market Attractiveness Analysis, by Product Type
7. Global Veterinary Imaging Market Analysis and Forecast, by Animal Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Animal Type, 2017–2031
7.3.1. Small Animals
7.3.2. Large Animals
7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Imaging Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Oncology
8.3.2. Orthopedics
8.3.3. Neurology
8.3.4. Cardiology
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Veterinary Imaging Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Veterinary Clinics
9.3.2. Veterinary Hospitals
9.3.3. Veterinary Institutes & Research Centers
9.4. Market Attractiveness Analysis, by End-user
10. Global Veterinary Imaging Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Veterinary Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Equipment
11.2.1.1. Radiography (X-ray)
11.2.1.2. Ultrasound Imaging
11.2.1.3. Magnetic Resonance Imaging (MRI)
11.2.1.4. Computed Tomography
11.2.1.5. Endoscopy
11.2.1.6. Others
11.2.2. Imaging Reagents
11.2.3. Imaging Software
11.3. Market Value Forecast, by Animal Type, 2017–2031
11.3.1. Small Animals
11.3.2. Large Animals
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Oncology
11.4.2. Orthopedics
11.4.3. Neurology
11.4.4. Cardiology
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Veterinary Clinics
11.5.2. Veterinary Hospitals
11.5.3. Veterinary Institutes & Research Centers
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Animal Type
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Veterinary Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Equipment
12.2.1.1. Radiography (X-ray)
12.2.1.2. Ultrasound Imaging
12.2.1.3. Magnetic Resonance Imaging (MRI)
12.2.1.4. Computed Tomography
12.2.1.5. Endoscopy
12.2.1.6. Others
12.2.2. Imaging Reagents
12.2.3. Imaging Software
12.3. Market Value Forecast, by Animal Type, 2017–2031
12.3.1. Small Animals
12.3.2. Large Animals
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Oncology
12.4.2. Orthopedics
12.4.3. Neurology
12.4.4. Cardiology
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Veterinary Clinics
12.5.2. Veterinary Hospitals
12.5.3. Veterinary Institutes & Research Centers
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Animal Type
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Veterinary Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Equipment
13.2.1.1. Radiography (X-ray)
13.2.1.2. Ultrasound Imaging
13.2.1.3. Magnetic Resonance Imaging (MRI)
13.2.1.4. Computed Tomography
13.2.1.5. Endoscopy
13.2.1.6. Others
13.2.2. Imaging Reagents
13.2.3. Imaging Software
13.3. Market Value Forecast, by Animal Type, 2017–2031
13.3.1. Small Animals
13.3.2. Large Animals
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Oncology
13.4.2. Orthopedics
13.4.3. Neurology
13.4.4. Cardiology
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Veterinary Clinics
13.5.2. Veterinary Hospitals
13.5.3. Veterinary Institutes & Research Centers
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Animal Type
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Veterinary Imaging Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Equipment
14.2.1.1. Radiography (X-ray)
14.2.1.2. Ultrasound Imaging
14.2.1.3. Magnetic Resonance Imaging (MRI)
14.2.1.4. Computed Tomography
14.2.1.5. Endoscopy
14.2.1.6. Others
14.2.2. Imaging Reagents
14.2.3. Imaging Software
14.3. Market Value Forecast, by Animal Type, 2017–2031
14.3.1. Small Animals
14.3.2. Large Animals
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Oncology
14.4.2. Orthopedics
14.4.3. Neurology
14.4.4. Cardiology
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Veterinary Clinics
14.5.2. Veterinary Hospitals
14.5.3. Veterinary Institutes & Research Centers
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Animal Type
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Veterinary Imaging Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Equipment
15.2.1.1. Radiography (X-ray)
15.2.1.2. Ultrasound Imaging
15.2.1.3. Magnetic Resonance Imaging (MRI)
15.2.1.4. Computed Tomography
15.2.1.5. Endoscopy
15.2.1.6. Others
15.2.2. Imaging Reagents
15.2.3. Imaging Software
15.3. Market Value Forecast, by Animal Type, 2017–2031
15.3.1. Small Animals
15.3.2. Large Animals
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Oncology
15.4.2. Orthopedics
15.4.3. Neurology
15.4.4. Cardiology
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Veterinary Clinics
15.5.2. Veterinary Hospitals
15.5.3. Veterinary Institutes & Research Centers
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Animal Type
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. 3M
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Johnson & Johnson
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medtronic Plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. GE Healthcare
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Koninklijke Philips N.V.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Samsung
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
